
Andy Gump deformity | Journal of Clinical, Medical and …
Sep 22, 2017 · The patient underwent wide local excision with central arch resection of mandible with bilateral modified neck dissection and pectoralis major myocutaneous flap for reconstruction followed by postoperative radiotherapy. During the follow up, patient developed severe “Andy Gump deformity” [Figure 1].
Improving Patient Monitoring in the Setting of Metastatic HSPC
Jul 12, 2022 · What are the benefits of subcutaneous drug formulations? How does daratumumab improve multiple myeloma treatment outcomes? Closing out their discussion on a clinical scenario of metastatic HSPC,...
HSPC - Heat Safety Performance Coalition
The Heat Safety & Performance Coalition (HSPC) provides heat-safety research, education, and awareness and was created to help organizations develop and implement heat safety solutions to keep workers safe.
Andy Cromer - Principal - HSPG & Associates, PC | LinkedIn
Principal at HSPG & Associates, PC · CPA and audit partner with over 20 years of experience directing a wide range of audits, including manufacturing entities, trucking, health care,...
- Title: Principal at HSPG & …
- Location: HSPG & Associates, PC
- Connections: 198
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances …
In the past 5 years, several systemic therapies have been introduced for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). While androgen deprivation therapy (ADT) remains the mainstay of treatment of mHSPC, docetaxel chemotherapy and oral anti-androgens have demonstrated survival benefit when added to ADT.
Single-cell panleukemia signatures of HSPC-like blasts predict …
We identified a core transcriptional regulatory network (TRN) in HSPC-like blasts that is combinatorically controlled by HOXA/AP1/CEBPA. This TRN signature can predict chemotherapy response and long-term clinical outcomes.
Prostate Cancer Foundation Hormone-Sensitive Prostate Cancer …
Sep 1, 2021 · Androgen deprivation therapy remains the backbone therapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC).
Hematopoietic stem and progenitor cell signaling in the niche
Oct 19, 2020 · Here, we review evidence of signals emerging from HSPCs through secreted autocrine or paracrine factors, including extracellular vesicles, and via direct contact within the niche. We also discuss...
Modification of hematopoietic stem/progenitor cells with CD19 ... - PubMed
We propose gene transfer to hematopoietic stem/progenitor cells (HSPC) as a novel approach to deliver the CD19-specific CAR, with potential for ensuring persistent production of effector cells of multiple lineages targeting B-lineage malignant cells.
Treatment of Hormone-Sensitive Prostate Cancer for Urologists
Mar 15, 2024 · Formulate personalized treatment plans for patients with HSPC, considering patient-specific factors, up-to-date best-practice treatment strategies, recent clinical trial findings, and expert recommendations